Home / Stocks / SYK

Stryker (SYK, Health Care Equipment) Stock Valuation & Fair Value Mixed on our tests

Stryker (SYK, Health Care Equipment) trades at a blended P/E of 18.8, about 17% below its historical normal valuation, with a forward growth estimate of 11.3% and a PEG of 1.66. Analysts' one-year estimates have been hit 91% of the time. Priced at its historical normal P/E of 22.6 on the same blended earnings, the 2026-10-02 close of $275.43 corresponds to about $332 a share. This is a valuation reference, not a price target.

DATA AS OF 2026-10-05
Blended P/E
18.8
Normal P/E
22.6
PEG
1.66
Fwd growth
11.3%
Div yield
1.3%
RSI (14)
42.7
Neutral
Technical context
  • Price $276.97 at the 2026-10-08 close, 0.2% above the 20-day average ($276.30) and 9.3% below the 50-day ($305.37).
  • RSI (14) at 42.7.
  • 52-week range $268.90 to $384.17: the price is 27.9% below the high and 3.0% above the low.

The Street vs SeerForecast

Wall Street's mean price target for SYK is $367.80 across 25 analysts, 32.8% above the current price. The average analyst rating is Buy. Our SeerForecast read of the same stock, formed without analyst targets: mixed on our tests. When the two disagree, start your digging there.

Valuation flags

Verdict history

tickerseer's rating moved from weak on forward returns (2026-06-03) to mixed on our tests (2026-10-05).

Blended P/E and rating by weekBlended P/E moved from 21.7 to 18.8 between 2026-06-03 and 2026-10-02, against a normal P/E of 22.6, with 1 rating change over 37 recorded weeks.2026-06-03: P/E 21.7, Weak on forward returns, recalculated for the week of 2026-06-032026-06-10: P/E 21.5, Weak on forward returns, recalculated for the week of 2026-06-102026-06-12: P/E 21.5, Weak on forward returns, recalculated for the week of 2026-06-142026-06-16: P/E 21.5, Weak on forward returns, recalculated for the week of 2026-06-162026-06-18: P/E 21.5, Weak on forward returns, recalculated for the week of 2026-06-212026-07-02: P/E 21.9, Weak on forward returns, recalculated for the week of 2026-07-022026-07-06: P/E 22.8, Weak on forward returns, recalculated for the week of 2026-07-062026-07-09: P/E 22.8, Weak on forward returns, recalculated for the week of 2026-07-092026-07-10: P/E 23.0, Weak on forward returns, recalculated for the week of 2026-07-122026-07-13: P/E 23.0, Weak on forward returns, recalculated for the week of 2026-07-132026-07-14: P/E 23.0, Weak on forward returns, recalculated for the week of 2026-07-142026-07-20: P/E 22.3, Weak on forward returns, recalculated for the week of 2026-07-202026-07-22: P/E 22.3, Weak on forward returns, recalculated for the week of 2026-07-222026-07-24: P/E 22.9, Weak on forward returns, recalculated for the week of 2026-07-252026-07-27: P/E 22.9, Weak on forward returns, recalculated for the week of 2026-07-272026-07-31: P/E 24.1, Weak on forward returns, recalculated for the week of 2026-07-312026-07-31: P/E 22.6, Weak on forward returns, recorded live 2026-08-032026-08-07: P/E 23.3, Weak on forward returns, recalculated for the week of 2026-08-072026-08-07: P/E 23.4, Weak on forward returns, recorded live 2026-08-102026-08-14: P/E 23.5, Weak on forward returns, recalculated for the week of 2026-08-142026-08-14: P/E 23.4, Weak on forward returns, recorded live 2026-08-172026-08-21: P/E 22.6, Weak on forward returns, recalculated for the week of 2026-08-212026-08-21: P/E 22.7, Weak on forward returns, recorded live 2026-08-242026-08-27: P/E 22.7, Weak on forward returns, recalculated for the week of 2026-08-272026-08-28: P/E 22.1, Weak on forward returns, recalculated for the week of 2026-08-282026-08-28: P/E 22.7, Weak on forward returns, recalculated for the week of 2026-08-302026-08-28: P/E 22.7, Weak on forward returns, recorded live 2026-08-312026-09-04: P/E 20.8, Weak on forward returns, recalculated for the week of 2026-09-052026-09-04: P/E 20.8, Weak on forward returns, recorded live 2026-09-072026-09-11: P/E 18.9, Mixed on our tests, recalculated for the week of 2026-09-122026-09-11: P/E 18.9, Mixed on our tests, recorded live 2026-09-142026-09-18: P/E 18.8, Mixed on our tests, recalculated for the week of 2026-09-192026-09-18: P/E 18.8, Mixed on our tests, recorded live 2026-09-212026-09-25: P/E 18.6, Mixed on our tests, recalculated for the week of 2026-09-262026-09-25: P/E 18.6, Mixed on our tests, recorded live 2026-09-282026-10-02: P/E 18.8, Mixed on our tests, recalculated for the week of 2026-10-032026-10-02: P/E 18.8, Mixed on our tests, recorded live 2026-10-0520.022.024.0Jun 3Jul 3Aug 2Sep 2Oct 2Normal P/E 22.6
Mixed on our testsWeak on forward returns

Not every point was recorded live. Points marked recalculated apply today's valuation rules to the metrics tickerseer archived that week.

Selected weeks: the first, the latest, every week the rating moved, and the cheapest and dearest.

WeekBlended P/EPremium to normal P/ERating
2026-06-03P/E 21.7-4%Weak on forward returns (recalculated)
2026-07-31P/E 24.1+7%Weak on forward returns (recalculated)
2026-09-12P/E 18.9-17%Mixed on our tests (recalculated)
2026-09-26P/E 18.6-18%Mixed on our tests (recalculated)
2026-10-05P/E 18.8-17%Mixed on our tests ← now
Show all 37 weeks
WeekBlended P/EPremium to normal P/ERating
2026-06-03P/E 21.7-4%Weak on forward returns (recalculated)
2026-06-10P/E 21.5-5%Weak on forward returns (recalculated)
2026-06-14P/E 21.5-5%Weak on forward returns (recalculated)
2026-06-16P/E 21.5-5%Weak on forward returns (recalculated)
2026-06-21P/E 21.5-5%Weak on forward returns (recalculated)
2026-07-02P/E 21.9-3%Weak on forward returns (recalculated)
2026-07-06P/E 22.8+1%Weak on forward returns (recalculated)
2026-07-09P/E 22.8+1%Weak on forward returns (recalculated)
2026-07-12P/E 23.0+2%Weak on forward returns (recalculated)
2026-07-13P/E 23.0+2%Weak on forward returns (recalculated)
2026-07-14P/E 23.0+2%Weak on forward returns (recalculated)
2026-07-20P/E 22.3-2%Weak on forward returns (recalculated)
2026-07-22P/E 22.3-2%Weak on forward returns (recalculated)
2026-07-25P/E 22.9+1%Weak on forward returns (recalculated)
2026-07-27P/E 22.9+1%Weak on forward returns (recalculated)
2026-07-31P/E 24.1+7%Weak on forward returns (recalculated)
2026-08-03P/E 22.6-0%Weak on forward returns
2026-08-07P/E 23.3+3%Weak on forward returns (recalculated)
2026-08-10P/E 23.4+4%Weak on forward returns
2026-08-14P/E 23.5+4%Weak on forward returns (recalculated)
2026-08-17P/E 23.4+3%Weak on forward returns
2026-08-21P/E 22.6-0%Weak on forward returns (recalculated)
2026-08-24P/E 22.7+0%Weak on forward returns
2026-08-27P/E 22.7+0%Weak on forward returns (recalculated)
2026-08-28P/E 22.1-2%Weak on forward returns (recalculated)
2026-08-30P/E 22.7+0%Weak on forward returns (recalculated)
2026-08-31P/E 22.7+0%Weak on forward returns
2026-09-05P/E 20.8-8%Weak on forward returns (recalculated)
2026-09-07P/E 20.8-8%Weak on forward returns
2026-09-12P/E 18.9-17%Mixed on our tests (recalculated)
2026-09-14P/E 18.9-17%Mixed on our tests
2026-09-19P/E 18.8-17%Mixed on our tests (recalculated)
2026-09-21P/E 18.8-17%Mixed on our tests
2026-09-26P/E 18.6-18%Mixed on our tests (recalculated)
2026-09-28P/E 18.6-18%Mixed on our tests
2026-10-03P/E 18.8-17%Mixed on our tests (recalculated)
2026-10-05P/E 18.8-17%Mixed on our tests ← now

Frequently asked questions

Is Stryker stock overvalued?

At a blended P/E of 18.8 versus its historical normal P/E of 22.6, Stryker trades about 17% below its typical valuation, with a PEG of 1.66 on 11.3% forward growth. tickerseer currently rates it mixed on our tests.

What is Stryker's fair value and PEG?

Stryker trades at a blended P/E of 18.8 against a historical normal P/E of 22.6, a PEG of 1.66, and a forward growth estimate of 11.3%. Priced at its historical normal P/E of 22.6 on the same blended earnings, the 2026-10-02 close of $275.43 corresponds to about $332 a share. This is a valuation reference, not a price target.

Has tickerseer's rating of Stryker changed?

tickerseer's rating moved from weak on forward returns (2026-06-03) to mixed on our tests (2026-10-05).

What is the analyst price target for Stryker?

The mean Wall Street price target for Stryker is $367.80 across 25 analysts, 32.8% above the current price. tickerseer's SeerForecast verdict is formed independently of analyst targets.

Industry: Health Care Equipment. Create a free account to see the full analysis: the SeerAI score, its five quality sub-scores, valuation history, and the AI research note. Options setups and metric history are part of the paid plans.

See the full analysis →🔔 Track SYK free: valuation & earnings alerts

Get the free weekly earnings preview

One email each Monday with the week's named earnings setups, the reasoning, and what settled last week. Strikes and sizing stay in Premium.

It's free, and you can unsubscribe any time. We also send a short product update once a month. Educational content, not investment advice.